Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas

Chest

Volumn 109, Issue 1, 1996, Pages 109-114

  Johansson, Leif ^a   Lindén, Carl Johan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

histopathology; immunohistochemistry; pleural mesothelioma; prognosis

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PLEURA BIOPSY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030032572     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.1.109     Document Type: Article

References (27)

1. Gibbs AR. Role of asbestos and other fibres in the development of diffuse malignant mesothelioma. Thorax 1990; 45:649-54
2. Law MR, Gregor A, Hodson ME, et al. Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax 1984; 39:255-59
3. Vogelzang NJ. Malignant mesothelioma: diagnostic and management strategies for 1992. Semin Oncol 1992; 19(suppl 11):64-71
4. Krarup-Hansen A, Hansen HH. Chemotherapy in malignant mesothelioma: a review. Cancer Chemother Pharmacol 1991; 28:319-30
5. Mattson K, Holsti LR, Tammilehto L, et al. Multimodality treatment programs for malignant pleural mesotheliomas using high-dose hemithorax irradiation. Int J Radiat Oncol Biol Phys 1992; 24:643-50
6. Manzini VP, Brollo A, Franceschi S, et al. Prognostic factors of malignant mesothelioma of the pleura. Cancer 1993; 72:410-17
7. Van Gelder T. Prognostic factors and survival in malignant pleural mesothelioma. Eur Respir J 1994; 7:1035-38
8. Alberts AS, Falkson C, Goedhels L, et al. Malignant pleural mesothelioma: a disease unaffected by current therapeutic manoenvres. J Clin Oncol 1988; 6:527-35
9. Antman KH, Shemin R, Klegar K, et al. Malignant mesothelioma; prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol 1988; 6:607-13
10. Ruffie P, Feld R, Cormier S, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 1989; 7:1157-68
11. Chahinian AP, Pajak TF, Holland JF, et al. Diffuse malignant mesothelioma: prospective evaluation of 69 patients. Ann Intern Med 1982; 96(pt 1):746-55
12. Fusco V, Ardizzoni A, Merlo F, et al. Malignant pleural mesothelioma: multivariate analysis of prognostic factors on 113 patients: clinical study. Anticancer Res 1993; 13:683-90
13. Elmes PC, Simpson MJC. The clinical aspects of mesothelioma. Q J Med 1976; 45:427-49
14. Hartmann CA, Schütze H. Survival and frequency of metastasis in histological subtypes of pleural mesothelioma: autopsy study of 106 cases. Pathologe 1992; 13:259-68
15. Sugarbaker DJ, Strauss GM, Lynch TJ, et al. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 1993; 11:1172-78
16. Hulks G, Thomas J StJ, Waclawski E. Malignant pleural mesothelioma in western Glasgow 1980-86. Thorax 1989; 44:496-500
17. Van Gelder T. Hoogsteden HC, Vandenbroncke JP, et al. The influence of the diagnostic technique on the histopathological diagnosis of malignant mesotheliomas. Virchows Arch A Pathol Anat 1991; 418:315-17
18. The World Health Organization histological typing of lung tumours. Am J Clin Pathol 1982; 77:123-36
19. Hammar SP, Bolen JW. Pleural neoplasms. In: Dail DH, Hammar SP, eds. Pulmonary pathology. New York: Springer-Verlag, 1988; 973-1028
20. Butchart EG, Ashcroft T, Barnsley WA, et al. Pleuro-peumonectomy in the management of diffuse malignant mesothelioma of the pleura. Thorax 1976; 31:15-24
21. Johansson L, Lindén CJ. Review of malignant mesotheliomas in Lund 1980-90: histopathological and immunohistochemical features: preliminary results. Eur Respir Rev 1993; 3:61-3
22. Klemperer P, Rabin CB. Primary neoplasms of the pleura: a report of five cases. Arch Pathol 1931; 11:385-412
23. McCaughey WT. Primary tumours of the pleura. J Pathol Bact 1958; 76:517-29
24. Loddenkemper R, Bontin C. Thoracoscopy: present diagnostic and therapeutic indications. Eur Respir J 1993; 10:1544-55
25. Sheibani K. Immunopathology of malignant mesothelioma [editorial]. Hum Pathol 1994; 25:219-20
26. Mezger J, Latnerz R, Permanetter W. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma. J Thorac Cardiovasc Surg, 1990; 100:860-66
27. Law MR, Hodson ME, Heard BE. Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax 1982; 37:810-15